Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Frontotemporal Dementia | 10 | 2022 | 248 | 1.330 |
Why?
|
| Alzheimer Disease | 13 | 2023 | 8038 | 1.270 |
Why?
|
| Frontotemporal Lobar Degeneration | 6 | 2022 | 99 | 1.110 |
Why?
|
| Aphasia, Primary Progressive | 4 | 2020 | 73 | 1.050 |
Why?
|
| Atrophy | 11 | 2023 | 1584 | 0.870 |
Why?
|
| tau Proteins | 10 | 2023 | 1868 | 0.730 |
Why?
|
| Lewy Body Disease | 1 | 2022 | 229 | 0.690 |
Why?
|
| Deglutition Disorders | 1 | 2023 | 606 | 0.580 |
Why?
|
| Dementia | 5 | 2019 | 2518 | 0.570 |
Why?
|
| Supranuclear Palsy, Progressive | 3 | 2022 | 77 | 0.520 |
Why?
|
| Cerebral Cortex | 7 | 2021 | 5709 | 0.520 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 2 | 2012 | 89 | 0.500 |
Why?
|
| Neuropsychological Tests | 11 | 2020 | 6994 | 0.470 |
Why?
|
| Prions | 2 | 2012 | 180 | 0.450 |
Why?
|
| Amyloid beta-Peptides | 3 | 2023 | 3587 | 0.450 |
Why?
|
| Pattern Recognition, Visual | 1 | 2019 | 824 | 0.450 |
Why?
|
| Neurodegenerative Diseases | 3 | 2022 | 1061 | 0.370 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2775 | 0.310 |
Why?
|
| Epilepsy | 1 | 2023 | 3310 | 0.290 |
Why?
|
| Memory Disorders | 3 | 2023 | 1186 | 0.250 |
Why?
|
| Positron-Emission Tomography | 5 | 2023 | 6234 | 0.240 |
Why?
|
| Communicable Diseases | 1 | 2011 | 880 | 0.220 |
Why?
|
| Pick Disease of the Brain | 1 | 2022 | 43 | 0.210 |
Why?
|
| Executive Function | 3 | 2020 | 1364 | 0.200 |
Why?
|
| Brain | 13 | 2023 | 26388 | 0.200 |
Why?
|
| Aging | 4 | 2018 | 8664 | 0.190 |
Why?
|
| Amnesia | 1 | 2023 | 248 | 0.190 |
Why?
|
| Organic Chemicals | 1 | 2021 | 211 | 0.190 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 328 | 0.170 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2020 | 51 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2020 | 17446 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2023 | 35425 | 0.170 |
Why?
|
| Carbolines | 2 | 2017 | 265 | 0.160 |
Why?
|
| Memory, Short-Term | 2 | 2018 | 977 | 0.160 |
Why?
|
| Amyloid | 1 | 2023 | 795 | 0.150 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 295 | 0.150 |
Why?
|
| Occipital Lobe | 1 | 2019 | 379 | 0.150 |
Why?
|
| Perceptual Disorders | 1 | 2019 | 196 | 0.150 |
Why?
|
| Hyponatremia | 1 | 2020 | 298 | 0.140 |
Why?
|
| Middle Aged | 26 | 2022 | 213390 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 789 | 0.140 |
Why?
|
| Aged | 19 | 2023 | 163288 | 0.130 |
Why?
|
| Disease Progression | 5 | 2020 | 13286 | 0.120 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2015 | 105 | 0.120 |
Why?
|
| Geniculate Bodies | 1 | 2015 | 163 | 0.120 |
Why?
|
| Pons | 1 | 2015 | 245 | 0.120 |
Why?
|
| Mutation | 6 | 2022 | 29786 | 0.120 |
Why?
|
| Humans | 42 | 2023 | 744366 | 0.120 |
Why?
|
| Language | 2 | 2022 | 1471 | 0.120 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2018 | 403 | 0.120 |
Why?
|
| Cognition | 3 | 2021 | 6770 | 0.120 |
Why?
|
| Basal Ganglia | 1 | 2016 | 546 | 0.120 |
Why?
|
| Hallucinations | 1 | 2015 | 360 | 0.110 |
Why?
|
| Male | 30 | 2023 | 350115 | 0.110 |
Why?
|
| Vision Disorders | 1 | 2019 | 1058 | 0.100 |
Why?
|
| Female | 28 | 2022 | 380193 | 0.100 |
Why?
|
| Mental Recall | 1 | 2018 | 1206 | 0.100 |
Why?
|
| Psychology | 1 | 2013 | 356 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2020 | 1860 | 0.090 |
Why?
|
| Fatal Outcome | 2 | 2012 | 1851 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2020 | 8949 | 0.090 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2010 | 150 | 0.090 |
Why?
|
| Caregivers | 1 | 2020 | 2095 | 0.080 |
Why?
|
| Glucuronates | 1 | 1988 | 40 | 0.080 |
Why?
|
| Field Dependence-Independence | 1 | 2008 | 25 | 0.080 |
Why?
|
| Glycosphingolipids | 1 | 1988 | 79 | 0.080 |
Why?
|
| Visual Cortex | 1 | 2015 | 1149 | 0.080 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 57776 | 0.070 |
Why?
|
| Myelin Proteins | 1 | 1988 | 215 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 270 | 0.070 |
Why?
|
| Evoked Potentials, Visual | 1 | 2008 | 427 | 0.060 |
Why?
|
| Paraproteinemias | 1 | 1988 | 246 | 0.060 |
Why?
|
| Nerve Net | 2 | 2015 | 2175 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12961 | 0.060 |
Why?
|
| Motor Cortex | 1 | 2011 | 986 | 0.060 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 13991 | 0.060 |
Why?
|
| Reaction Time | 1 | 2010 | 2098 | 0.060 |
Why?
|
| Quality of Life | 2 | 2022 | 12802 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 1901 | 0.050 |
Why?
|
| Biological Availability | 1 | 2021 | 397 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 2 | 2000 | 1144 | 0.040 |
Why?
|
| Memory | 1 | 2008 | 2174 | 0.040 |
Why?
|
| Psychomotor Disorders | 1 | 2019 | 152 | 0.040 |
Why?
|
| Language Disorders | 1 | 2019 | 141 | 0.040 |
Why?
|
| Limbic System | 1 | 2000 | 426 | 0.040 |
Why?
|
| Adult | 11 | 2021 | 214052 | 0.040 |
Why?
|
| Attention | 1 | 2008 | 2397 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 1988 | 1622 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 1997 | 337 | 0.030 |
Why?
|
| North America | 1 | 2020 | 1249 | 0.030 |
Why?
|
| Visual Perception | 2 | 2019 | 1420 | 0.030 |
Why?
|
| Syndrome | 1 | 2022 | 3252 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2011 | 6670 | 0.030 |
Why?
|
| Verbal Learning | 1 | 2018 | 468 | 0.030 |
Why?
|
| Social Behavior | 1 | 2022 | 1127 | 0.030 |
Why?
|
| Water Deprivation | 1 | 1994 | 21 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 25039 | 0.030 |
Why?
|
| Checklist | 1 | 2022 | 833 | 0.030 |
Why?
|
| Physicians | 1 | 2013 | 4567 | 0.030 |
Why?
|
| Young Adult | 4 | 2020 | 56429 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 1994 | 232 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2022 | 40559 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2018 | 838 | 0.030 |
Why?
|
| Immunoglobulin M | 2 | 1988 | 1537 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 2804 | 0.030 |
Why?
|
| Age of Onset | 1 | 2019 | 3270 | 0.030 |
Why?
|
| Language Tests | 1 | 2013 | 202 | 0.030 |
Why?
|
| Adolescent | 4 | 2020 | 85779 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2020 | 1670 | 0.030 |
Why?
|
| Visual Pathways | 1 | 2015 | 565 | 0.020 |
Why?
|
| Reference Values | 3 | 2008 | 4982 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 1265 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 1997 | 1091 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 2887 | 0.020 |
Why?
|
| Animals | 3 | 2013 | 168768 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2018 | 1828 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2000 | 2732 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1590 | 0.020 |
Why?
|
| Polysomnography | 1 | 2015 | 1776 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 2305 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1994 | 1063 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2460 | 0.020 |
Why?
|
| Anxiety | 2 | 2000 | 4293 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2018 | 1916 | 0.020 |
Why?
|
| Glucuronic Acid | 1 | 1988 | 148 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 1988 | 113 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2737 | 0.020 |
Why?
|
| Gangliosides | 1 | 1988 | 137 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 2645 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 2593 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2013 | 1406 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1988 | 414 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 1988 | 247 | 0.020 |
Why?
|
| Seizures | 1 | 2018 | 2859 | 0.020 |
Why?
|
| Semantics | 1 | 2008 | 585 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2019 | 4043 | 0.020 |
Why?
|
| Glucose | 1 | 1997 | 4398 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 780 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 1997 | 3747 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2010 | 2026 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1988 | 844 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2008 | 1056 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18373 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15535 | 0.010 |
Why?
|
| Environment | 1 | 2008 | 1123 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2015 | 3265 | 0.010 |
Why?
|
| Depression | 1 | 2000 | 7759 | 0.010 |
Why?
|
| Imagination | 1 | 2000 | 221 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 77460 | 0.010 |
Why?
|
| Supraoptic Nucleus | 1 | 1994 | 28 | 0.010 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1994 | 70 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39052 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1994 | 199 | 0.010 |
Why?
|
| Tritium | 1 | 1994 | 745 | 0.010 |
Why?
|
| Putamen | 1 | 1994 | 291 | 0.010 |
Why?
|
| Mood Disorders | 1 | 2000 | 1106 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 1994 | 253 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2008 | 6151 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1994 | 393 | 0.010 |
Why?
|
| Stroke | 1 | 2015 | 9981 | 0.010 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 1994 | 211 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1988 | 9274 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1994 | 896 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1997 | 2016 | 0.000 |
Why?
|
| Nerve Tissue | 1 | 1988 | 79 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1997 | 6366 | 0.000 |
Why?
|
| G(M1) Ganglioside | 1 | 1988 | 96 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1994 | 3749 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 2505 | 0.000 |
Why?
|
| Epitopes | 1 | 1988 | 2571 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1997 | 15078 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1988 | 2036 | 0.000 |
Why?
|
| Rats | 1 | 1994 | 24252 | 0.000 |
Why?
|
| Prognosis | 1 | 1997 | 29060 | 0.000 |
Why?
|
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_